TickerFacts.

Fortrea Holdings Inc. (FTRE): Shareholders' Equity

Annual figures by period end, from SEC filings.

$563.50M
As of 2025-12-31
$524.20M
As of 2026-06-30
-44.7%
3-year compound annual growth
$3.34B2021-12-31: $3.26B2022-12-31: $3.34B2023-12-31: $1.71B2024-12-31: $1.36B2025-12-31: $563.50M$563.50M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$563.50M-58.6%2026-02-26, Balance as of period end
2024-12-31$1.36B-20.5%2026-02-26, Balance as of period end
2023-12-31$1.71B-48.7%2026-02-26, Balance as of period end
2022-12-31$3.34B+2.4%2025-03-03, Balance as of period end
2021-12-31$3.26Bn/a2024-03-13, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31$563.50M-58.6%
Natera, Inc. (NTRA)2025-12-31$1.71B+43.2%
RadNet, Inc. (RDNT)2025-12-31$1.36B+19.6%
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$7.21B+5.8%
Labcorp Holdings Inc. (LH)2025-12-31$8.62B+7.0%
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗